China's biotech boom alarms Western lawmakers, investors

China's growing influence in biotechnology has raised concerns among Western lawmakers and investors. US companies like Eli Lilly and Pfizer have formed partnerships with Chinese firms, sparking fears of over-reliance and potential geopolitical risks. Analysts compare China's biotech advantages to its dominance in the electric vehicle sector, citing factors like cost efficiency and supply chain integration.